Publications by authors named "Shane D Scott"

Claim this Profile
D
Drug-induced QT-interval prolongation: considerations for clinicians.
Edward C Li, John S Esterly, Shaunte Pohl, Shane D Scott, Brian F McBride

Pharmacotherapy· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapy.
Elizabeth A Chrischilles, Donald G Klepser, John M Brooks, Margaret D Voelker, Shari S Chen-Hardee, Shane D Scott

Pharmacotherapy· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma.
Elizabeth A Chrischilles, Brian K Link, Shane D Scott, David J Delgado, Moshe Fridman

Cancer Control· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy.
Shane D Scott, Elizabeth A Chrischilles, Brian K Link, David J Delgado, Moshe Fridman

J Manag Care Pharm· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa.
John M Brooks, Elizabeth A Chrischilles, Shane D Scott, Shari S Chen-Hardee

Health Serv Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticholinergic agents for the treatment of "death rattle" in patients with myasthenia gravis.
Jeffrey L Spiess, Shane D Scott

J Pain Symptom Manage· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing anemia in patients with chronic kidney disease or cancer: development and role of darbepoetin alfa.
Shane D Scott

Pharmacotherapy· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose conversion from recombinant human erythropoietin to darbepoetin alfa: recommendations from clinical studies.
Shane D Scott

Pharmacotherapy· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis